Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Watanabe Pharmaceutical Industry Co., Ltd. is a Japanese contract development and manufacturing organization (CDMO) and pharmaceutical company headquartered in Toyama, Japan. Founded in 1908, the company has over a century of experience in the production of oral solid dosage forms, including tablets, granules, and capsules. It is particularly renowned for its specialized expertise in sugar-coating technology, which is used to enhance the stability and palatability of medications. Watanabe Pharmaceutical Industry provides comprehensive manufacturing services, from formulation design and research to large-scale production and packaging, serving as a key partner for numerous major pharmaceutical firms in Japan. The company operates GMP-compliant facilities and focuses on the stable supply of high-quality pharmaceuticals, quasi-drugs, and health foods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Watanabe Pharmaceutical.